0 NASDAQ Companies - October 7, 2020Preferred Bank Announces 2020 Third Quarter Earnings Release and Conference CallLOS ANGELES, Oct. 07, 2020 (GLOBE NEWSWIRE) — Preferred Bank (NASDAQ: PFBC), an independent commercial bank focusing on the diversified […]Read More
0 NASDAQ Companies - October 7, 2020Duck Creek Technologies Announces Date of Fourth Quarter and Full Year Fiscal 2020 Earnings CallBay Street NewsRead More
0 NASDAQ Companies - October 7, 2020PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of Fourth Fiscal Quarter 2020 ResultsBay Street NewsRead More
0 NASDAQ Companies - October 7, 2020Financial Institutions, Inc. Announces Completion of $35 Million Private Placement of Subordinated NotesBay Street NewsRead More
0 NASDAQ Companies - October 7, 2020Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis ConferenceBay Street NewsRead More
0 NASDAQ Companies - October 7, 2020Caladrius Biosciences to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the MesaBASKING RIDGE, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage […]Read More
0 NASDAQ Companies - October 7, 2020TTM Technologies, Inc. To Conduct Third Quarter 2020 Conference Call October 28, 2020SANTA ANA, Calif., Oct. 07, 2020 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ:TTMI) will host a conference call on Wednesday, […]Read More
0 NASDAQ Companies - October 7, 2020PennantPark Investment Corporation Schedules Earnings Release of Fourth Fiscal Quarter 2020 ResultsNEW YORK, Oct. 07, 2020 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (the “Company”) (NASDAQ: PNNT) announced that it will report […]Read More
0 NASDAQ Companies - October 7, 2020Verizon Response: Hurricane DeltaWhat you need to know:As Hurricane Delta heads towards the Gulf Coast, our emergency response teams are busy making sure […]Read More
0 NASDAQ Companies - October 7, 2020Sorrento Announces the Discovery of Salicyn-30 Small Molecule That Strongly Inhibits SARS-CoV-2 Infection in Preclinical Studies and Highlights its Place in a Potential Multi-Modal Therapy Strategy in Combination With Neutralizing Antibodies Against COVID-19In preclinical studies, Salicyn-30, a small molecule, demonstrated potent in-vitro viral load reduction of 3-4 log in SARS-CoV-2 infection model […]Read More